256 related articles for article (PubMed ID: 17768113)
21. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
Smith RE; Bryant J; DeCillis A; Anderson S;
J Clin Oncol; 2003 Apr; 21(7):1195-204. PubMed ID: 12663705
[TBL] [Abstract][Full Text] [Related]
22. Two different classes of therapy-related and de-novo acute myeloid leukemia?
Pedersen-Bjergaard J; Philip P
Cancer Genet Cytogenet; 1991 Aug; 55(1):119-24. PubMed ID: 1655239
[TBL] [Abstract][Full Text] [Related]
23. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
24. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
25. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.
Zompi S; Viguié F
Leuk Lymphoma; 2002 Feb; 43(2):275-80. PubMed ID: 11999558
[TBL] [Abstract][Full Text] [Related]
26. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
27. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
28. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
[TBL] [Abstract][Full Text] [Related]
29. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
Hake CR; Graubert TA; Fenske TS
Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301
[TBL] [Abstract][Full Text] [Related]
30. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Sandoval C; Pui CH; Bowman LC; Heaton D; Hurwitz CA; Raimondi SC; Behm FG; Head DR
J Clin Oncol; 1993 Jun; 11(6):1039-45. PubMed ID: 8388919
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review.
Pedersen-Bjergaard J
Leuk Res; 1992; 16(1):61-5. PubMed ID: 1732675
[TBL] [Abstract][Full Text] [Related]
32. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
33. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
35. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop.
Slovak ML; Bedell V; Popplewell L; Arber DA; Schoch C; Slater R
Genes Chromosomes Cancer; 2002 Apr; 33(4):379-94. PubMed ID: 11921272
[TBL] [Abstract][Full Text] [Related]
36. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
Darrington DL; Vose JM; Anderson JR; Bierman PJ; Bishop MR; Chan WC; Morris ME; Reed EC; Sanger WG; Tarantolo SR
J Clin Oncol; 1994 Dec; 12(12):2527-34. PubMed ID: 7989926
[TBL] [Abstract][Full Text] [Related]
37. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Rubin CM; Larson RA; Anastasi J; Winter JN; Thangavelu M; Vardiman JW; Rowley JD; Le Beau MM
Blood; 1990 Dec; 76(12):2594-8. PubMed ID: 2265251
[TBL] [Abstract][Full Text] [Related]
38. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
[TBL] [Abstract][Full Text] [Related]
39. Deletion of chromosome arm 3p in hematologic malignancies.
Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
[TBL] [Abstract][Full Text] [Related]
40. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]